ABCC7 p.Ser158Asn
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 12820707
[PubMed]
Hicks K et al: "Cystic fibrosis: S158N (605G --> A) is a rare genetic variant found in coupling with deltaF508."
No.
Sentence
Comment
1
Cystic Fibrosis: S158N (605G R A) Is a Rare Genetic Variant Found in Coupling with DF508 KAREN HICKS, WENDY BEADLING, and ANTONY E. SHRIMPTON ABSTRACT A single nucleotide change at codon 158 in exon 4 of the CFTR gene ABCC7 was detected in an asymptomatic individual who carried DF508 and had a family history of cystic fibrosis (CF).
X
ABCC7 p.Ser158Asn 12820707:1:17
status: NEW2 Further study, using linkage, revealed that S158N was coupled with DF508, both having been inherited from the same parent.
X
ABCC7 p.Ser158Asn 12820707:2:44
status: NEW22 This transition of a G to A occurs at nucleotide 605; the second nucleotide of codon 158, is predicted to result in the substitution of an asparagine (AAT) for a serine (AGT), hence the designation S158N.
X
ABCC7 p.Ser158Asn 12820707:22:198
status: NEW23 Follow-up testing on the patient`s parents and affected sibling surprisingly showed that S158N and DF508 were in coupling, having been inherited from the same parent (Fig. 4).
X
ABCC7 p.Ser158Asn 12820707:23:89
status: NEW29 To our surprise, we found that the new mutation, S158N, was coupled with DF508.
X
ABCC7 p.Ser158Asn 12820707:29:49
status: NEW31 Thus, we describe S158N as a rare genetic variant.
X
ABCC7 p.Ser158Asn 12820707:31:18
status: NEW40 Serine to asparagineat codon158: S158N (605G R A).
X
ABCC7 p.Ser158Asn 12820707:40:33
status: NEW42 CF: S158N (605G R A).
X
ABCC7 p.Ser158Asn 12820707:42:4
status: NEW48 Additional studies will be needed to determine whether S158N is such a modifying mutation, a primary pathologic mutation, or a benign variant.
X
ABCC7 p.Ser158Asn 12820707:48:55
status: NEW49 If the S158N/DF508 genotype had first been detected in the CF-affected child, rather than as in this case, in an unaffected sibling, how often would a family study to determine linkage have been initiated?
X
ABCC7 p.Ser158Asn 12820707:49:7
status: NEW
PMID: 18782298
[PubMed]
Sharma N et al: "Identification and characterization of CFTR gene mutations in Indian CF patients."
No.
Sentence
Comment
2
We report identification of 14 previously known and eight novel mutations, namely 3986-3987delC, 876-6del4, 1792InsA, L69H, S158N, Q493L, I530L and E1329Q.
X
ABCC7 p.Ser158Asn 18782298:2:124
status: NEW67 They included nine missense mutations (L69H, S158N, Q493L, Y517C, V520F, I530L, S549N, E1329Q, and Y1381H), one insertion mutation (1792insA), three splice site mutations (876-6del4, 1525-1G-A, 3120+1G-A), two deletion mutations (1161delC, 3986delC), and 1 nonsense mutation (L218X).
X
ABCC7 p.Ser158Asn 18782298:67:45
status: NEW73 Novel Mutations and Phenotypic Features Output prediction scores were assessed for five novel mutations; they were >0.5 for L69H & Q493L and <0.5 for S158N, I530L & E1329Q (Table 3).
X
ABCC7 p.Ser158Asn 18782298:73:150
status: NEW79 S158N The chief complaint of the 13 yr old patient, compound heterozygous for S158N, was recurrent coughs for the last five years.
X
ABCC7 p.Ser158Asn 18782298:79:0
status: NEWX
ABCC7 p.Ser158Asn 18782298:79:78
status: NEW96 Table 2 Genotypes of CF subjects (n=50) Genotype Number of subjects Delta F508/Delta F508 5 Delta F508/3849+10kb C-T 1 Delta F508/S549N 2 Delta F508/S158N 1 Delta F508/Y1381H 1 Delta F508/1525-1 G-A 2 V520F/R117H 1 I530L/I530L 1 876-6del4/876-6del4 1 1792ins A/1792insA 1 3986-3987delC/3986-3987delC 1 Delta F508/U 10 1161 delC/U 2 L69H/U 1 R117H/U 1 Q493L/U 1 Y517C/U 1 S549N/U 3 G551D/U 1 E1329Q/U 1 N1303K/U 1 Y1381H/U 1 L218X/U 1 R553X/U 1 1525-1G-A/U 3 3120+1G-A/U 2 3849+10kb C-T/U 2 U/U 1 U-unidentified Table 3 Outcome prediction scores of novel substitution mutations identified in Indian CF patients Wild type Mutant Position Output Reliablity Prediction L H 69 0.5210 0 Pathological S N 158 0.3304 3 Neutral Q L 493 0.7784 5 Pathological I L 530 0.0591 8 Neutral E Q 1329 0.1018 7 Neutral Molecular Modelling and Bioinformatics (MMB) program (http://mmb.pcb.ub.es/PMut/) was used for pathological predictions of novel sequence variants.
X
ABCC7 p.Ser158Asn 18782298:96:149
status: NEW113 We first identified five of the mutations by ARMS (Delta F508, R117H, R553X, N1303K & G551D) and one by restriction digestion (3849+10kbC-T) and later identified by SSCP eight known (Y517C, V520F, S549N, Y1381H, 1525-1G-A, 3120+1G-A, 1161delC and L218X) and eight previously unreported mutations (L69H, S158N, Q493L, I530L, E1329Q, 876-6del4, 1792insA and 3986-3987delC).
X
ABCC7 p.Ser158Asn 18782298:113:303
status: NEW133 Output prediction scores deduced using molecular modeling and a bioinformatics program (http://mmb.pcb.ub.es/PMut/) revealed that among the novel mutations, L69H and Q493L are pathologic but S158N, I530L and E1329Q are neutral.
X
ABCC7 p.Ser158Asn 18782298:133:191
status: NEW
PMID: 21966101
[PubMed]
Prasad R et al: "Molecular basis of cystic fibrosis disease: an Indian perspective."
No.
Sentence
Comment
99
The other seven known but rare mutations (1161delC, Y517C, V520F, S549N, Y1381H, L218X and 1525-1G-A) were identified at a combined frequency of (17%), and eight new mutations (3986delC, 1792InsA, L69H, S158N, Q493L, I530L, E1329Q and 876-8del4) identified in our CF population represented (15%) of the total CF alleles analyzed.
X
ABCC7 p.Ser158Asn 21966101:99:203
status: NEW